Search research articles
Contact Us
Filters
Showing results (11-20 of 84) with videos related to
Page
of 9
Sort By:
The American Journal of Pathology
|
October 28, 2003
Amplification of a 280-kilobase core region at the ERBB2 locus leads to activation of two hypothetical proteins in breast cancer
Päivikki Kauraniemi, Tuula Kuukasjärvi, Guido Sauter, et al.
Cancer Detection and Prevention
|
November 23, 2006
Large genomic BRCA2 rearrangements and male breast cancer
Ritva Karhu, Eeva Laurila, Anne Kallioniemi, et al.
Breast Cancer Research and Treatment
|
September 28, 2006
A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7
Emma-Leena Alarmo, Tuula Kuukasjärvi, Ritva Karhu, et al.
Cancer Genetics and Cytogenetics
|
March 11, 2008
PPM1D silencing by RNA interference inhibits proliferation and induces apoptosis in breast cancer cell lines with wild-type p53
Jenita Pärssinen, Emma-Leena Alarmo, Ritva Karhu, et al.
Anticancer Research
|
December 26, 2012
Silencing of the ARP2/3 complex disturbs pancreatic cancer cell migration
Hanna E Rauhala, Susanna Teppo, Sanna Niemelä, et al.
International Journal of Cancer
|
August 10, 2004
Frequent amplification and overexpression of CCND1 in male breast cancer
Maarit Bärlund, Tuula Kuukasjärvi, Kirsi Syrjäkoski, et al.
Cancer Genetics and Cytogenetics
|
November 8, 2005
Search for large genomic alterations of the BRCA1 gene in a Finnish population
Eeva Laurila, Kirsi Syrjäkoski, Kaija Holli, et al.
Genes, Chromosomes & Cancer
|
January 16, 2009
Characterization of the 7q21-q22 amplicon identifies ARPC1A, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion in pancreatic cancer
Eeva Laurila, Kimmo Savinainen, Riina Kuuselo, et al.
BMC Cancer
|
October 28, 2018
Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4-1 and NRDP1, in primary breast cancer
Satu Luhtala, Synnöve Staff, Anne Kallioniemi, et al.
Experimental Cell Research
|
November 27, 2013
KPNA7, a nuclear transport receptor, promotes malignant properties of pancreatic cancer cells in vitro
Eeva Laurila, Elisa Vuorinen, Kimmo Savinainen, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 84) with videos related to
Sort By:
Page
of 9
The American Journal of Pathology
|
October 28, 2003
Amplification of a 280-kilobase core region at the ERBB2 locus leads to activation of two hypothetical proteins in breast cancer
Päivikki Kauraniemi, Tuula Kuukasjärvi, Guido Sauter, et al.
Cancer Detection and Prevention
|
November 23, 2006
Large genomic BRCA2 rearrangements and male breast cancer
Ritva Karhu, Eeva Laurila, Anne Kallioniemi, et al.
Breast Cancer Research and Treatment
|
September 28, 2006
A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7
Emma-Leena Alarmo, Tuula Kuukasjärvi, Ritva Karhu, et al.
Cancer Genetics and Cytogenetics
|
March 11, 2008
PPM1D silencing by RNA interference inhibits proliferation and induces apoptosis in breast cancer cell lines with wild-type p53
Jenita Pärssinen, Emma-Leena Alarmo, Ritva Karhu, et al.
Anticancer Research
|
December 26, 2012
Silencing of the ARP2/3 complex disturbs pancreatic cancer cell migration
Hanna E Rauhala, Susanna Teppo, Sanna Niemelä, et al.
International Journal of Cancer
|
August 10, 2004
Frequent amplification and overexpression of CCND1 in male breast cancer
Maarit Bärlund, Tuula Kuukasjärvi, Kirsi Syrjäkoski, et al.
Cancer Genetics and Cytogenetics
|
November 8, 2005
Search for large genomic alterations of the BRCA1 gene in a Finnish population
Eeva Laurila, Kirsi Syrjäkoski, Kaija Holli, et al.
Genes, Chromosomes & Cancer
|
January 16, 2009
Characterization of the 7q21-q22 amplicon identifies ARPC1A, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion in pancreatic cancer
Eeva Laurila, Kimmo Savinainen, Riina Kuuselo, et al.
BMC Cancer
|
October 28, 2018
Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4-1 and NRDP1, in primary breast cancer
Satu Luhtala, Synnöve Staff, Anne Kallioniemi, et al.
Experimental Cell Research
|
November 27, 2013
KPNA7, a nuclear transport receptor, promotes malignant properties of pancreatic cancer cells in vitro
Eeva Laurila, Elisa Vuorinen, Kimmo Savinainen, et al.
Page
of 9